The insulin market is heading for a shakeup. But patients may not benefit

(By Rebecca Robbins for STAT)

The insulin market, dominated by old drugs that have skyrocketed in price, is on the verge of a shakeup. Continue reading article here…….


Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or